TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35236568

Group type: EXPERIMENTAL
Intervention: High tumour-infiltrating lymphocytes (TILs) prevalence (TILshigh)
Number of subjects: 711

Group type: EXPERIMENTAL
Intervention: High TILs in HER2-negative DCIS
Number of subjects: 711

Group type: EXPERIMENTAL
Intervention: Including TILs-status in clinical workup
Number of subjects: 711
Study: 33543410

Group type: EXPERIMENTAL
Intervention: Intensive strength training 3 times/week (3 × 10 repetitions at 80% of one‐repetition maximum)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Strength endurance training (2 × 30 repetitions at 40% of one‐repetition maximum)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Control (passive stretching exercise)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: AHTD users
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: ARB users
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Statin users
Number of subjects: 179
Study: 32088746

Group type: EXPERIMENTAL
Intervention: Fexapotide triflutate 2.5 mg
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Fexapotide triflutate 15 mg
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control Active Surveillance
Number of subjects: 146
Study: 34402360

Group type: EXPERIMENTAL
Intervention: Continuous combined estradiol 0.5 mg + dydrogesterone 2.5 mg
Number of subjects: 332

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 332
Study: 32667105

Group type: EXPERIMENTAL
Intervention: MICRA (Motivational Interviewing and Community Reinforcement Approach)
Number of subjects: 79

Group type: COMPARATOR
Intervention: TAU (Treatment as Usual)
Number of subjects: 79
Study: 34365978

Group type: COMPARATOR
Intervention: Berberine (Be)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Bifidobacterium (Bi)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Berberine and Bifidobacterium (BB)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 32398130

Group type: EXPERIMENTAL
Intervention: Communication skills training (group training)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control group (CG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Communication skills training
Number of subjects: 0
Study: 35942523

Group type: EXPERIMENTAL
Intervention: text+visual intervention
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: text-only intervention
Number of subjects: 145

Group type: COMPARATOR
Intervention: control
Number of subjects: 145
Study: 34785173

Group type: EXPERIMENTAL
Intervention: Intravenous nicorandil (6 mg as a bolus before reperfusion, followed by 48 hours of continuous infusion at a dose of 6 mg/h)
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Placebo (same dosage as nicorandil)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Intravenous nicorandil
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1500
Study: 32871687

Group type: EXPERIMENTAL
Intervention: Mindfulness Meditation, Reiki, Acupuncture, and Auriculotherapy (experimental group)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 21
Study: 33794164

Group type: EXPERIMENTAL
Intervention: Sutureless surgical valve
Number of subjects: 680

Group type: COMPARATOR
Intervention: Sutured surgical valve
Number of subjects: 680
Study: 34540991

Group type: EXPERIMENTAL
Intervention: Carbohydrate beverage administered 2 hours before endoscopy
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Carbohydrate beverage administered 4 hours before endoscopy
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (no carbohydrate supplementation for 8 hours before endoscopy)
Number of subjects: 180
Study: 36116674

Group type: COMPARATOR
Intervention: 5.25% NaOCl + 17% EDTA (Control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Zn(II) Ce6 methyl ester + 17% EDTA
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 400 nm femtosecond laser + 17% EDTA
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Curcumin activated by PDT + 17% EDTA
Number of subjects: 40
Study: 32123242

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) for 15 weeks
Number of subjects: 55

Group type: COMPARATOR
Intervention: Sedentary Control
Number of subjects: 55
Study: 33848338

Group type: EXPERIMENTAL
Intervention: 5 mg THC and 0.06 mg CBD daily (Treatment A)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 10 mg THC and 0.12 mg CBD daily (Treatment B)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 15 mg THC and 0.18 mg CBD daily (Treatment C)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 20 mg THC and 0.24 mg CBD daily (Treatment D)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41

Group type: COMPARATOR
Intervention: Treatment D vs Placebo
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Treatment A vs Treatment B
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Treatment B vs Treatment D
Number of subjects: 41
Study: 33276789

Group type: EXPERIMENTAL
Intervention: Interprofessional case-based learning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monoprofessional case-based learning
Number of subjects: 0
Study: 32638095

Group type: EXPERIMENTAL
Intervention: Expectant management
Number of subjects: 174

Group type: COMPARATOR
Intervention: Misoprostol (800 µg single dose)
Number of subjects: 174
Study: 35674652

Group type: EXPERIMENTAL
Intervention: Asynchronous telehealth visits
Number of subjects: 23
Study: 32663286

Group type: EXPERIMENTAL
Intervention: App-based mindfulness-meditation program (10 min daily for 30 days)
Number of subjects: 46
Study: 32023539

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (5,000 IU daily for 12 weeks)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 35037520

Group type: EXPERIMENTAL
Intervention: Parent-mediated intervention (Social ABCs)
Number of subjects: 179
Study: 34698499

Group type: EXPERIMENTAL
Intervention: Belimumab
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 32026827

Group type: EXPERIMENTAL
Intervention: Progressive exercise programme
Number of subjects: 708

Group type: COMPARATOR
Intervention: Best-practice advice
Number of subjects: 708
Study: 35150309

Group type: EXPERIMENTAL
Intervention: Multifamily group intervention
Number of subjects: 72

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 72
Study: 34194315

Group type: EXPERIMENTAL
Intervention: EEG-based neurofeedback training to enhance upper alpha frequency
Number of subjects: 0

Group type: COMPARATOR
Intervention: Random feedbacks (Sham group)
Number of subjects: 0
Study: 35149112

Group type: EXPERIMENTAL
Intervention: Risk priming group
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Effectiveness priming group
Number of subjects: 147

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 147
Study: 32102725

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 37
Study: 34319427

Group type: EXPERIMENTAL
Intervention: Low-calorie diets containing 20% fat and 25% protein
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Low-calorie diets containing 40% fat and 15% protein
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Low-calorie diets with varying carbohydrate percentages
Number of subjects: 540
Study: 35692982

Group type: EXPERIMENTAL
Intervention: True natural cycle (true NC‐) frozen embryo transfer (FET) using urinary LH tests
Number of subjects: 1464

Group type: COMPARATOR
Intervention: Modified natural cycle (mNC‐FET) using repeated ultrasound monitoring and ovulation trigger
Number of subjects: 1464

Group type: EXPERIMENTAL
Intervention: Cost estimation based on resource use and unit prices
Number of subjects: 1464

Group type: EXPERIMENTAL
Intervention: Neonatal outcomes
Number of subjects: 1464
Study: 33452056

Group type: EXPERIMENTAL
Intervention: Hormonal contraceptive (HC) use with self-reported adverse mood symptoms
Number of subjects: 302

Group type: COMPARATOR
Intervention: Women without self-reported HC-induced adverse mood symptoms
Number of subjects: 302
Study: 32701587

Group type: EXPERIMENTAL
Intervention: Physiotherapy interventions aimed at improving walking speed
Number of subjects: 227

Group type: COMPARATOR
Intervention: Journals' Impact Factor
Number of subjects: 227

Group type: COMPARATOR
Intervention: Open access journals endorsing CONSORT recommendations
Number of subjects: 227
Study: 36058201

Group type: EXPERIMENTAL
Intervention: Cortisol (10 mg hydrocortisone)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 32915009

Group type: EXPERIMENTAL
Intervention: Deliberate Practice (DP) workshop
Number of subjects: 68

Group type: COMPARATOR
Intervention: Traditional workshop
Number of subjects: 68

Group type: COMPARATOR
Intervention: Both groups (DP and Traditional)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Simulators (both groups)
Number of subjects: 68
Study: 32439141

Group type: EXPERIMENTAL
Intervention: NICE guidelines
Number of subjects: 46

Group type: COMPARATOR
Intervention: ESVS guidelines
Number of subjects: 46
Study: 36151864

Group type: EXPERIMENTAL
Intervention: Combination therapy (apremilast 10 mg to 60 mg + phototherapy)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Monotherapy (phototherapy only)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 42

Group type: COMPARATOR
Intervention: Monotherapy
Number of subjects: 42
Study: 33918724

Group type: EXPERIMENTAL
Intervention: BMGIM music therapy (8 sessions over 8 weeks)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 43
Study: 34773428

Group type: EXPERIMENTAL
Intervention: Wind turbine noise at sound pressure levels of 33 dBA, 38 dBA, and 43 dBA
Number of subjects: 23

Group type: COMPARATOR
Intervention: Road traffic noise at sound pressure levels of 33 dBA, 38 dBA, and 43 dBA
Number of subjects: 23
Study: 33196566

Group type: EXPERIMENTAL
Intervention: Apex-centered capsulotomy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard pupil-centered capsulotomy
Number of subjects: 40
Study: 33296365

Group type: EXPERIMENTAL
Intervention: Routine deworming combined with a behaviour change intervention promoting handwashing with water and soap.
Number of subjects: 320

Group type: COMPARATOR
Intervention: Routine deworming (control group).
Number of subjects: 320
Study: 35347418

Group type: EXPERIMENTAL
Intervention: Live music therapy (4-week duration)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Live music therapy
Number of subjects: 62

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 62
Study: 33536545

Group type: EXPERIMENTAL
Intervention: Antidepressant use (specific types include fluoxetine, paroxetine, escitalopram, venlafaxine, mirtazapine)
Number of subjects: 7230
Study: 35586878

Group type: EXPERIMENTAL
Intervention: TAU augmented with meditation and yoga training (MYT)
Number of subjects: 145

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: TAU augmented with Yoga training (YT)
Number of subjects: 145
Study: 34323984

Group type: EXPERIMENTAL
Intervention: Clinician-facing intervention providing information about patient analgesic treatment preference and risk of opioid misuse.
Number of subjects: 1302

Group type: EXPERIMENTAL
Intervention: Patients who preferred opioids (Black patients)
Number of subjects: 1302

Group type: EXPERIMENTAL
Intervention: Patients who did not prefer opioids (Black patients)
Number of subjects: 1302
Study: 35889747

Group type: EXPERIMENTAL
Intervention: Oral Arthrospira at 3 g daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Oral Arthrospira at 6 g daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no Arthrospira)
Number of subjects: 60
Study: 33682549

Group type: EXPERIMENTAL
Intervention: Combined Kegel and yoga exercise for 3 months
Number of subjects: 74

Group type: COMPARATOR
Intervention: Kegel exercise
Number of subjects: 74
Study: 32843164

Group type: EXPERIMENTAL
Intervention: IND/GLY/MF high-dose (150/50/160 μg) once-daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IND/GLY/MF medium-dose (150/50/80 μg) once-daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: SAL/FLU high-dose (50/500 μg) twice-daily + TIO 5 μg once-daily
Number of subjects: 0
Study: 36429797

Group type: EXPERIMENTAL
Intervention: Directed vestibular rehabilitation therapy (VRT) plus manual therapy (MT) once a week for 4 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Directed vestibular rehabilitation therapy (VRT)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Directed vestibular rehabilitation therapy (VRT) plus manual therapy (MT)
Number of subjects: 80
Study: 34222637

Group type: EXPERIMENTAL
Intervention: Nasocystic irrigation with hydrogen peroxide (H2O2)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Biflanged metal stent (BMS)
Number of subjects: 50
Study: 32940630

Group type: EXPERIMENTAL
Intervention: Willingness to discuss clinical trials
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Group-based medical suspicion
Number of subjects: 205

Group type: COMPARATOR
Intervention: Demographic comparisons
Number of subjects: 205
Study: 35357104

Group type: EXPERIMENTAL
Intervention: Rice at early supper (5:00 p.m.)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Rice at breakfast (8:00 a.m.)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Rice at lunch (12:30 p.m.)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Rice meals (all times)
Number of subjects: 34
Study: 33024299

Group type: EXPERIMENTAL
Intervention: Real tDCS
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 12
Study: 33856385

Group type: EXPERIMENTAL
Intervention: ERAS group
Number of subjects: 370

Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 370
Study: 32305871

Group type: EXPERIMENTAL
Intervention: High triterpenic acid content olive oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low triterpenic acid content olive oil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pentacyclic triterpenes consumption
Number of subjects: 0
Study: 34778910

Group type: EXPERIMENTAL
Intervention: High HRSc (≥70%)
Number of subjects: 1471

Group type: EXPERIMENTAL
Intervention: High MIHR (>70 bpm)
Number of subjects: 1471

Group type: EXPERIMENTAL
Intervention: Continuous HRSc increase
Number of subjects: 1471

Group type: EXPERIMENTAL
Intervention: Continuous MIHR increase
Number of subjects: 1471
Study: 34934126

Group type: EXPERIMENTAL
Intervention: Insulin Resistance (IR)
Number of subjects: 835
Study: 35950566

Group type: EXPERIMENTAL
Intervention: Selpercatinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35491558

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham (placebo) treatment
Number of subjects: 30
Study: 34620087

Group type: EXPERIMENTAL
Intervention: Intracranial pressure (ICP) measurements at baseline, 12 months, and 24 months
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Intracranial pressure (ICP) measurements at 12 months
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Intracranial pressure (ICP) measurements at 12 and 24 months
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Intracranial pressure (ICP) measurements
Number of subjects: 66
Study: 32808036

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Never-treated
Number of subjects: 34

Group type: COMPARATOR
Intervention: Healthy control
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Clozapine vs Risperidone
Number of subjects: 34
Study: 36459413

Group type: EXPERIMENTAL
Intervention: HARK
Number of subjects: 40

Group type: COMPARATOR
Intervention: HAJUS
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both HARK and HAJUS
Number of subjects: 40
Study: 32706659

Group type: EXPERIMENTAL
Intervention: Diet and PA module
Number of subjects: 619

Group type: EXPERIMENTAL
Intervention: Diet module
Number of subjects: 619

Group type: EXPERIMENTAL
Intervention: No module
Number of subjects: 619

Group type: EXPERIMENTAL
Intervention: PA module only
Number of subjects: 619

Group type: COMPARATOR
Intervention: Strong advice to follow diet module
Number of subjects: 619
Study: 35395758

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 521

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) with thorough information
Number of subjects: 521

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) with brain circuitry-based causal explanation
Number of subjects: 521
Study: 32897905

Group type: EXPERIMENTAL
Intervention: Low systolic blood pressure (SBP <120 mmHg)
Number of subjects: 11083

Group type: EXPERIMENTAL
Intervention: Low diastolic blood pressure (DBP <70 mmHg)
Number of subjects: 11083

Group type: COMPARATOR
Intervention: Normal SBP (≥120 mmHg)
Number of subjects: 11083

Group type: COMPARATOR
Intervention: Normal DBP (≥70 mmHg)
Number of subjects: 11083
Study: 36276341

Group type: EXPERIMENTAL
Intervention: Virtual reality technology combined with conventional rehabilitation strategies
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional/routine clinical rehabilitation training
Number of subjects: 44
Study: 36334390

Group type: EXPERIMENTAL
Intervention: RYN plus standard care
Number of subjects: 2830
Study: 35611516

Group type: EXPERIMENTAL
Intervention: Transcatheter mitral valve repair (TMVR) with the MitraClip device
Number of subjects: 307

Group type: COMPARATOR
Intervention: Guideline-directed medical therapy (GDMT)
Number of subjects: 307
Study: 32141723

Group type: EXPERIMENTAL
Intervention: OLZ/SAM
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 401

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 401
Study: 35091135

Group type: EXPERIMENTAL
Intervention: Prediabetes Clinical Decision Support (CDS) tool
Number of subjects: 34

Group type: COMPARATOR
Intervention: No access to Pre-D CDS tool (Control)
Number of subjects: 34
Study: 34717700

Group type: EXPERIMENTAL
Intervention: LOV group (tidal volume of 3‐4 ml/kg, respiratory rate of 10‐12 bpm, PEEP of 5‐8 cmH2O, FiO2 30%)
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: HOV group (same ventilation parameters as LOV group, FiO2 80%)
Number of subjects: 413

Group type: COMPARATOR
Intervention: NoV group (no mechanical ventilation during CPB)
Number of subjects: 413
Study: 32901066

Group type: EXPERIMENTAL
Intervention: 11 SNPs associated with 28 outcomes (Bonferroni corrected P value < 4.63·10‐6)
Number of subjects: 422417

Group type: EXPERIMENTAL
Intervention: Multiple SNP MR analysis
Number of subjects: 422417
Study: 35660801

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 217

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217
Study: 32926502

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MED)
Number of subjects: 12

Group type: COMPARATOR
Intervention: High-fibre vegetarian diet (HFV)
Number of subjects: 12
Study: 32408153

Group type: EXPERIMENTAL
Intervention: Calorie restriction (daily or intermittently)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Time-restricted feeding (TRF) diet
Number of subjects: 90

Group type: COMPARATOR
Intervention: Calorie restriction and time-restricted feeding
Number of subjects: 90
Study: 34788110

Group type: EXPERIMENTAL
Intervention: Second-line ART without resistance
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Cumulative genotypic susceptibility score (cGSS)
Number of subjects: 214
Study: 35636225

Group type: EXPERIMENTAL
Intervention: Comprehensive swallowing intervention for 4 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (swallowing care only)
Number of subjects: 60
Study: 32712560

Group type: EXPERIMENTAL
Intervention: Pimavanserin 34 mg once daily
Number of subjects: 459
Study: 34611042

Group type: COMPARATOR
Intervention: Conventional antibiotic treatment
Number of subjects: 400

Group type: COMPARATOR
Intervention: Partial oral antibiotic treatment
Number of subjects: 400
Study: 32861652

Group type: EXPERIMENTAL
Intervention: TMVr for MR-dominant (MD) patients
Number of subjects: 1016

Group type: EXPERIMENTAL
Intervention: TMVr for MR-LV-co-dominant (MLCD) patients
Number of subjects: 1016

Group type: EXPERIMENTAL
Intervention: TMVr for LV-dominant (LD) patients
Number of subjects: 1016

Group type: EXPERIMENTAL
Intervention: TMVr for all groups
Number of subjects: 1016
Study: 34919834

Group type: EXPERIMENTAL
Intervention: Agomelatine 25 mg/day (n=94)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Agomelatine 10 mg/day (n=102)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Fluoxetine 10-20 mg/day (n=99)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo (n=101)
Number of subjects: 400
Study: 33435869

Group type: EXPERIMENTAL
Intervention: FLS‐CARE (coordinated care programme)
Number of subjects: 1216

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1216
Study: 33393602

Group type: EXPERIMENTAL
Intervention: Numbee injection (needleless intraligamentary local anesthesia)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Traditional inferior alveolar nerve block (IANB)
Number of subjects: 15
Study: 34716214

Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 14671

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14671
Study: 33576107

Group type: EXPERIMENTAL
Intervention: Praziquantel (PZQ) treatment
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Real-time PCR screening
Number of subjects: 400
Study: 32301744

Group type: EXPERIMENTAL
Intervention: Telemonitoring interventions for the management of HDP
Number of subjects: 20
Study: 35995946

Group type: EXPERIMENTAL
Intervention: VR intervention to experience the environmental impact of food behavior
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: VR intervention
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Manipulation of normative feedback
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Manipulation of geographical framing
Number of subjects: 123
Study: 34593045

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (intranasal saline)
Number of subjects: 18
Study: 32873262

Group type: EXPERIMENTAL
Intervention: GlobalConsent
Number of subjects: 400

Group type: COMPARATOR
Intervention: Health-education attention control
Number of subjects: 400